Searched for
THERAPEUTIC SEGMENT
These large- and mid-cap stocks can give more than 20% return in 1 year, according to analysts- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analysts
- For investors looking beyond the short-term horizon: 5 mid-cap stocks from different sectors with upside potential up to 28%
- For investors with ability – and patience to wait 3 years, not 3 months: 6 large-cap stocks with upside potential of up to 33%The interesting point about the large-cap space today is not that prices have collapsed. In most cases, they have not. The more important c...28 Jun, 2026, 05.46 AM IST
- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...26 Jun, 2026, 11.31 AM IST
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 24%When business updates start to come in or when some FMCG or auto companies indicate that things are not all good in the rural space, we may...23 Jun, 2026, 07.51 AM IST
- Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...22 Jun, 2026, 12.25 PM IST
- These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...19 Jun, 2026, 11.50 AM IST
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...17 Jun, 2026, 03.08 PM IST
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...12 Jun, 2026, 12.25 PM IST
- Hexagon Nutrition shares list at 7% premium over IPO price on boursesHexagon Nutrition debuted at a premium of up to 7.2% over its IPO price, in line with grey market expectations. The Rs 138.9 crore issue wa...12 Jun, 2026, 11.32 AM IST
- Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tabletsConcord Biotech's shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approv...10 Jun, 2026, 01.11 PM IST
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...09 Jun, 2026, 07.34 PM IST
- West Bengal's electronics factory push; Fed jitters hit TCSWest Bengal is exploring ways to expand electronics manufacturing under EMC 2.0. This and more in today's ETtech Top 5.08 Jun, 2026, 07.40 PM IST
- Hexagon Nutrition IPO Day 2: GMP signals 15% listing gain; Retail portion subscribed 2.43xHexagon Nutrition’s Rs 139 crore IPO saw strong retail demand on Day 2, with the retail portion subscribed 2.43 times. The grey market prem...08 Jun, 2026, 10.23 AM IST
- Hexagon Nutrition IPO Day 1: 37% subscription, Grey market signals 27% listing gainHexagon Nutrition's IPO opened strongly on its first day. Retail investors showed significant interest, subscribing 62% of their quota. The...05 Jun, 2026, 12.18 PM IST
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...04 Jun, 2026, 09.43 PM IST
- Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...02 Jun, 2026, 03.30 PM IST
- IPO Calendar: Investors to get 2 mainboard public offers this week after a month of lullIndia’s IPO market is set to revive with two mainboard issues, CMR Green Technologies and Hexagon Nutrition, opening this week after a lull...31 May, 2026, 09.23 AM IST
- Supriya Lifescience shares surge 17% on strong Q4 earnings; PAT rises 47% YoYSupriya Lifescience shares jumped over 16% after the company posted a strong Q4FY26 performance, with PAT rising 47% YoY and revenue surgin...29 May, 2026, 11.29 AM IST
Load More
